BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24199658)

  • 1. NPHMC: an R-package for estimating sample size of proportional hazards mixture cure model.
    Cai C; Wang S; Lu W; Zhang J
    Comput Methods Programs Biomed; 2014; 113(1):290-300. PubMed ID: 24199658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. geecure: An R-package for marginal proportional hazards mixture cure models.
    Niu Y; Wang X; Peng Y
    Comput Methods Programs Biomed; 2018 Jul; 161():115-124. PubMed ID: 29852954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size calculation for the proportional hazards cure model.
    Wang S; Zhang J; Lu W
    Stat Med; 2012 Dec; 31(29):3959-71. PubMed ID: 22786805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CureAuxSP: An R package for estimating mixture cure models with auxiliary survival probabilities.
    Ding J; Li J; Zhang M; Wang X
    Comput Methods Programs Biomed; 2024 Jun; 251():108212. PubMed ID: 38754327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel sample size formula for the weighted log-rank test under the proportional hazards cure model.
    Xiong X; Wu J
    Pharm Stat; 2017 Jan; 16(1):87-94. PubMed ID: 27860138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unified approach to power and sample size determination for log-rank tests under proportional and nonproportional hazards.
    Tang Y
    Stat Methods Med Res; 2021 May; 30(5):1211-1234. PubMed ID: 33819109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations.
    Eaton A; Therneau T; Le-Rademacher J
    Clin Trials; 2020 Jun; 17(3):285-294. PubMed ID: 32063031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the Conditional Power in Survival Time Analysis Considering Cure Fractions.
    Kuehnapfel A; Schwarzenberger F; Scholz M
    Int J Biostat; 2017 Mar; 13(1):. PubMed ID: 28328527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size and power for the weighted log-rank test and Kaplan-Meier based tests with allowance for nonproportional hazards.
    Yung G; Liu Y
    Biometrics; 2020 Sep; 76(3):939-950. PubMed ID: 31797363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy trial design with long-term survivors.
    Ding X; Wu J
    Pharm Stat; 2021 Jan; 20(1):117-128. PubMed ID: 32869945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex survival trial design by the product integration method.
    Tang Y
    Stat Med; 2022 Feb; 41(4):798-814. PubMed ID: 34908180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Evaluation of a Method to Correct Misinterpretation of Clinical Trial Results With Long-term Survival.
    Hsu CY; Lin EP; Shyr Y
    JAMA Oncol; 2021 Jul; 7(7):1041-1044. PubMed ID: 33856410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A SAS macro for parametric and semiparametric mixture cure models.
    Corbière F; Joly P
    Comput Methods Programs Biomed; 2007 Feb; 85(2):173-80. PubMed ID: 17157948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size calculation for mixture model based on geometric average hazard ratio and its applications to nonproportional hazard.
    Wang Z; Zhang Q; Xue A; Whitmore J
    Pharm Stat; 2024; 23(3):325-338. PubMed ID: 38152873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flexible-hazards cure model with application to patients with soft tissue sarcoma.
    Xie C; Huang X; Li R; Pisters PWT
    Stat Med; 2022 Dec; 41(29):5698-5714. PubMed ID: 36165535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential tests for non-proportional hazards data.
    Brückner M; Brannath W
    Lifetime Data Anal; 2017 Jul; 23(3):339-352. PubMed ID: 26969674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weighted log-rank test for time-to-event data in immunotherapy trials with random delayed treatment effect and cure rate.
    Liu S; Chu C; Rong A
    Pharm Stat; 2018 Sep; 17(5):541-554. PubMed ID: 30058101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-component cure rate model for nonproportional hazards alternative in the design of randomized clinical trials.
    Kim HT; Gray R
    Clin Trials; 2012 Apr; 9(2):155-63. PubMed ID: 22353928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. smcure: an R-package for estimating semiparametric mixture cure models.
    Cai C; Zou Y; Peng Y; Zhang J
    Comput Methods Programs Biomed; 2012 Dec; 108(3):1255-60. PubMed ID: 23017250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A class of two-sample nonparametric statistics for binary and time-to-event outcomes.
    Bofill Roig M; Gómez Melis G
    Stat Methods Med Res; 2022 Feb; 31(2):225-239. PubMed ID: 34870495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.